TY - JOUR
T1 - Promoter methylation of SFRPs gene family in cervical cancer
AU - Chung, Ming Tzeung
AU - Sytwu, Huey Kang
AU - Yan, Ming De
AU - Shih, Yu Lueng
AU - Chang, Cheng Chang
AU - Yu, Mu Hsien
AU - Chu, Tang Yuan
AU - Lai, Hung Cheng
AU - Lin, Ya Wen
N1 - Funding Information:
We thank Dr. Steven B. Baylin (Department of Medicine, The Johns Hopkins University School of Medicine) for kindly providing the primer sequences of MSP for the SFRP genes. This work was supported in part by National Science Council, Taiwan, Republic of China (ROC); Grant numbers: the NSC95-2320-B-016-019-MY2; NSC96-3112-B-016-003; NSC97-3112-B-016-002; Tri-Service General Hospital, Taiwan, ROC; Grant numbers: TSGH-C95-7-S01; TSGH-C95-7-S02; TSGH-C95-7-S03; TSGH-C95-7-S04; the Armed Forces Tao-Yuan General Hospital, Tao-Yuan, Taiwan, ROC; Grant numbers; AFTYGH-9607; AFTYGH-9608; the Department of Health, Taiwan, Republic of China; Grant number; DOH97-TD-I-111-TM005.
PY - 2009/2
Y1 - 2009/2
N2 - Objectives: Oncogenic activation of the Wnt/β-catenin signaling pathway is common in human cancers, including cervical cancer. The secreted frizzled-related proteins (SFRPs) function as negative regulators of Wnt signaling and play an important role in carcinogenesis. Frequent promoter hypermethylation of SFRPs has been identified in human cancers; however, the precise role of SFRPs in cervical cancer is not clear. Methods: The methylation status of SFRPs gene family was analyzed in two cervical cancer cell lines and a full spectrum of cervical neoplasia, including 45 low-grade squamous intraepithelial lesions (LSIL), 49 high-grade squamous intraepithelial lesions (HSIL), 109 squamous cell carcinomas (SCC), and 45 normal controls. Results: The SFRP1 promoter was hypermethylated in 33.9% of SCC, 8.2% of HSIL, 2.2% of LSIL, but not in normal tissues. The SFRP2 promoter was hypermethylated in 80.7% of SCC, 16.3% of HSIL, 15.6% LSIL and 4.4% normal tissues. The SFRP4 promoter was hypermethylated in 67.9% of SCC, 36.7% of HSIL, 4.4% of LSIL, but not in normal tissues. The SFRP5 promoter was hypermethylated in 10.1% of SCC, 4.1% of HSIL, 13.3% of LSIL and 4.4% normal tissues. The frequency of SFRP1, SFRP2 and SFRP4 promoter methylation in tumors was significantly higher than in normal, LSIL, and HSIL samples (P < 0.0001). SFRP5 methylation was significantly different in patients with or without lymph-node metastases (0% vs 15.2%, respectively, P < 0.05). Conclusions: Our data suggest that promoter hypermethylation of SFRP1, SFRP2 and SFRP4 is associated with cervical carcinogenesis, which could be used for molecular screening of cervical neoplasias in future.
AB - Objectives: Oncogenic activation of the Wnt/β-catenin signaling pathway is common in human cancers, including cervical cancer. The secreted frizzled-related proteins (SFRPs) function as negative regulators of Wnt signaling and play an important role in carcinogenesis. Frequent promoter hypermethylation of SFRPs has been identified in human cancers; however, the precise role of SFRPs in cervical cancer is not clear. Methods: The methylation status of SFRPs gene family was analyzed in two cervical cancer cell lines and a full spectrum of cervical neoplasia, including 45 low-grade squamous intraepithelial lesions (LSIL), 49 high-grade squamous intraepithelial lesions (HSIL), 109 squamous cell carcinomas (SCC), and 45 normal controls. Results: The SFRP1 promoter was hypermethylated in 33.9% of SCC, 8.2% of HSIL, 2.2% of LSIL, but not in normal tissues. The SFRP2 promoter was hypermethylated in 80.7% of SCC, 16.3% of HSIL, 15.6% LSIL and 4.4% normal tissues. The SFRP4 promoter was hypermethylated in 67.9% of SCC, 36.7% of HSIL, 4.4% of LSIL, but not in normal tissues. The SFRP5 promoter was hypermethylated in 10.1% of SCC, 4.1% of HSIL, 13.3% of LSIL and 4.4% normal tissues. The frequency of SFRP1, SFRP2 and SFRP4 promoter methylation in tumors was significantly higher than in normal, LSIL, and HSIL samples (P < 0.0001). SFRP5 methylation was significantly different in patients with or without lymph-node metastases (0% vs 15.2%, respectively, P < 0.05). Conclusions: Our data suggest that promoter hypermethylation of SFRP1, SFRP2 and SFRP4 is associated with cervical carcinogenesis, which could be used for molecular screening of cervical neoplasias in future.
KW - Cervical cancer
KW - Epigenetic inactivation
KW - SFRP genes
UR - http://www.scopus.com/inward/record.url?scp=58249107838&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=58249107838&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2008.10.004
DO - 10.1016/j.ygyno.2008.10.004
M3 - Article
C2 - 19038436
AN - SCOPUS:58249107838
SN - 0090-8258
VL - 112
SP - 301
EP - 306
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 2
ER -